Tranquis Therapeutics to Present at Biotech Showcase and Participate in BIO @ JPM Partnering Conference

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Tranquis Therapeutics, a clinical stage private immuno-neurology company developing innovative medicines with the potential to revolutionize the management of neurodegenerative and aging-related diseases, today announced its CEO, Sanjak Kakkar, M.D. will give a corporate presentation at the Biotech Showcase, being held January 10-19, 2022. Tranquis Therapeutics will...

Click to view original post